Novel use of 308-nm excimer laser to treat a primary cutaneous CD30+ lymphoproliferative nodule.
CD30+ cutaneous lymphoproliferative disorders, the second most common cutaneous T cell lymphoma after mycosis fungoides, represent a spectrum of conditions ranging from lymphomatoid papulosis to borderline CD30+ lesions to anaplastic large-cell lymphoma. We report the case of a solitary cutaneous CD30+ lymphoproliferative nodule that was successfully treated with a 308-nm excimer laser. Our findings suggest that the 308-nm excimer laser may be a safe, effective, and well-tolerated therapy for primary localized CD30+ cutaneous lymphoproliferative lesions.
South Orlando Dermatology, Orlando, FL 32819, USA. luckyj@msn.com
John L
JL
Meisenheimer
D003937:Diagnosis, Differential; D006801:Humans; D007299:Insect Bites and Stings / Q000175:diagnosis; D017730:Ki-1 Antigen / Q000032:analysis*; D028022:Low-Level Light Therapy / Q000379:methods*; D017728:Lymphoma, Large-Cell, Anaplastic / Q000175:diagnosis / Q000276:immunology / Q000628:therapy*; D017731:Lymphomatoid Papulosis / Q000175:diagnosis / Q000276:immunology / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D013997:Time Factors; D016896:Treatment Outcome
D017730:Ki-1 Antigen